If you searched "compounded semaglutide 2026" or "is compounded semaglutide going away," you are not alone. The rules keep shifting, the FDA keeps issuing warnings, and the information online is a mess.
Here is the short version: compounded semaglutide is still legal in 2026, but the FDA has cracked down on bad actors, and the rules could change again if the shortage ends.
This article focuses on what changed, what is still legal, and exactly what to verify before you order.
What Changed in 2026
FDA Warning Letters: Three Pharmacies Cited
The FDA issued warning letters to three compounding pharmacies in early 2026. These are not abstract risks — they are real facilities where real patients received medications.
What inspectors found:
- Sterile injections being filled on a benchtop table in a room with carpeted floors
- A blood sample centrifuge running in the same room as sterile drug preparation
- Staff wearing non-sterile gloves during aseptic operations with exposed hair and skin
- A facility that approved drugs for distribution even after finding microbial contamination
- A product labeled as 1.25 mg that actually contained 1.75 mg — a 40% dosing error
- An operator with an uncovered skin condition who continued handling sterile products for three months
One pharmacy voluntarily recalled all its sterile products. Another had to recall a lot due to lack of sterility assurance.
What this means for you: These are not small technical violations. These are conditions that can put contaminated or incorrectly dosed medication into your body. See our compounded GLP-1 safety + legal guide for the full breakdown.
Enforcement Against Tirzepatide Compounding
The FDA also cited a pharmacy for repackaging compounded tirzepatide (the active ingredient in Mounjaro and Zepbound) under a branded name with added cyanocobalamin. This signals that the FDA is watching tirzepatide compounding too — not just semaglutide.
State-Level Rules Are Growing
Some states added their own compounding requirements in 2026:
- Texas and Florida — Additional inspections for compounding pharmacies
- California — Requires patient disclosure that compounded drugs are not FDA-approved
- Other states are considering similar rules
Check your state's board of pharmacy website for local requirements.
What Is Still Legal
Compounded semaglutide is legal when all three of these conditions are met:
-
The drug is on the FDA shortage list. Semaglutide injection is still listed as of April 2026. When it comes off the list, compounding becomes legally riskier.
-
The pharmacy is licensed and requires a prescription. No prescription = illegal. No license = illegal.
-
The active ingredient matches FDA-approved forms. The pharmacy must use semaglutide base — the same molecule as Ozempic and Wegovy. Salt forms (semaglutide sodium, semaglutide acetate) are different molecules that the FDA has warned against.
What Is NOT Legal
- Selling compounded semaglutide without a prescription
- Using salt forms instead of semaglutide base
- Calling it "generic Ozempic" or "generic Wegovy" (no FDA-approved generic exists)
- Compounding after the shortage ends (though enforcement here is inconsistent)
- Repackaging compounded drugs without proper sterile conditions
Shortage Status: The Big Question
This is the thing that could change everything.
As of April 2026: Semaglutide injection is still on the FDA Drug Shortage Database.
If the shortage ends: Compounding pharmacies are supposed to stop making compounded semaglutide. Some will. Some won't. The FDA's enforcement track record suggests they will go after the worst offenders, but not every pharmacy will get inspected immediately.
What to do: Check the FDA Drug Shortage Database before ordering. If semaglutide is no longer listed, talk to your doctor about switching to an FDA-approved option.
What to Verify Before You Order
Use this checklist. If a pharmacy cannot answer these clearly, find a different one.
The Four Must-Ask Questions
1. "Is this semaglutide base or semaglutide sodium/acetate salt?"
What you want to hear: "Semaglutide base."
Red flag: "It's all the same" or "we can't share that."
2. "Are you a 503A or 503B facility?"
What you want to hear: "503B" (higher FDA standards, regular inspections).
503A is not automatically bad — but 503B is safer for injectable medications.
3. "Can I see a certificate of analysis for this lot?"
What you want to hear: "Yes, here it is" — with a document showing potency, purity, and sterility testing from a third-party lab.
Red flag: "We do our own testing" or "we don't share that."
4. "Are you licensed in my state?"
What you want to hear: "Yes, here is our license number."
Verify it on your state board of pharmacy website.
Price Reality Check
| Source | Monthly Cost | Notes |
|---|---|---|
| Legitimate compounded (503B) | $300-$500 | Includes proper testing |
| Legitimate compounded (503A) | $200-$400 | Varies by state |
| Suspiciously cheap | Under $200 | Often salt forms or worse |
| Brand-name (no insurance) | $900-$1,400 | Ozempic, Wegovy |
| Brand-name (savings card) | $99-$500 | If you qualify |
Prices under $200/month for compounded semaglutide are a red flag. The real ingredient costs more than that to source properly.
If the Shortage Ends: What Happens
This is the scenario that drives the "is compounded semaglutide going away?" searches.
If the FDA removes semaglutide from the shortage list:
- Compounding becomes legally riskier — Pharmacies are supposed to stop, but some may not
- Your supply could disappear — Legitimate pharmacies will stop; sketchy ones may not
- Prices might change — Less competition could push remaining options higher
- FDA enforcement may increase — The agency tends to act more when shortage protections are gone
Prepare now: Talk to your doctor about backup options. Check if you qualify for manufacturer savings programs. Many patients can get brand-name for $99-$500/month if they have commercial insurance.
When to Choose Brand-Name Instead
Compounded semaglutide makes sense when:
- You cannot afford brand-name even with savings programs
- You do not have insurance that covers GLP-1s
- You have verified the pharmacy meets safety standards
Brand-name makes more sense when:
- You have commercial insurance that covers GLP-1s
- You qualify for a savings card (as low as $25/month for Zepbound)
- Your doctor recommends FDA-approved medication
- You want the certainty of tested, regulated medication
The Bottom Line
Compounded semaglutide is still legal in 2026, but the landscape is tighter than it was a year ago. The FDA found real safety problems at real pharmacies — carpeted cleanrooms, wrong doses, contaminated products. That does not mean all compounded semaglutide is dangerous. It means you need to verify your source carefully.
Check the shortage status. Ask the four questions. Verify the answers. And always explore brand-name savings programs before assuming compounded is your only option.
This article is for informational purposes only and does not constitute medical or legal advice. Always consult a licensed healthcare provider before starting any medication. Check the FDA Drug Shortage Database for current shortage status.
